News Next gen psoriasis drugs show superiority to Stelara Guselkumab can also be used if older drug Stellara fails.
News Valeant's Siliq approved but suicidal thoughts warning will ... But drug will have boxed warning over suicidal ideation.
News Delinia adds to Celgene's immunology ambitions Celgene continues with focus on autoimmune diseases.
News Amgen's Humira biosimilar first to gain EU nod But patents could delay launch for more than a year.
News AbbVie bullish on Humira and near-term pipeline Sales of Humira could peak above $18 billion - CEO
News Celgene broadens immunology presence with Anokion deal Biotech specialises in autoimmune disorder drugs.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.